Home - Products - Angiogenesis - EGFR - GSK-LSD1 dihydrochloride

GSK-LSD1 dihydrochloride

CAS No. 1431368-48-7

GSK-LSD1 dihydrochloride( —— )

Catalog No. M17295 CAS No. 1431368-48-7

GSK-LSD1 2HCl is a specificity irreversible LSD1 inhibitor (IC50: 16 nM). The selectivity of GSK-LSD1 for LSD1 is >1000 fold over other closely related FAD utilizing enzymes (i.e. MAO-A, LSD2, MAO-B).

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	62	In Stock
10MG	89	In Stock
25MG	148	In Stock
50MG	213	In Stock
100MG	319	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

GSK-LSD1 dihydrochloride
Note

Research use only, not for human use.
Brief Description

GSK-LSD1 2HCl is a specificity irreversible LSD1 inhibitor (IC50: 16 nM). The selectivity of GSK-LSD1 for LSD1 is >1000 fold over other closely related FAD utilizing enzymes (i.e. MAO-A, LSD2, MAO-B).
Description

GSK-LSD1 2HCl is a specificity irreversible LSD1 inhibitor (IC50: 16 nM). The selectivity of GSK-LSD1 for LSD1 is >1000 fold over other closely related FAD utilizing enzymes (i.e. MAO-A, LSD2, MAO-B).
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Angiogenesis
Target

EGFR
Recptor

LSD1
Research Area

Cancer
Indication

——

Chemical Information

CAS Number

1431368-48-7
Formula Weight

289.24
Molecular Formula

C14H22Cl2N2
Purity

>98% (HPLC)
Solubility

——
SMILES

c1ccc(cc1)[C@@H]1C[C@H]1NC1CCNCC1.Cl.Cl
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Structural Genomics Consortium.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Benidipine hydrochlo...

Benidipine HCl is a hydrochloride salt form of benidipine which is a dihydropyridine calcium channel blocker.
Varlitinib

Varlitinib is a selective and potent ErbB1(EGFR) and ErbB2(HER2) inhibitor with IC50 of 7 nM and 2 nM respectively. Phase 2.
EGFR-IN-7

EGFR-IN-7 is a selective and potent EGFR kinase inhibitor.TQB3804 displayed potent enzymatic activities for EGFRd746-750/T790M/C797S, EGFRL858R/T790M/C797S, EGFRd746-750/T790M, and EGFRL858R/T790M with IC50 of 0.46, 0.13, 0.26, and 0.19 nM respectively, and has similar enzymatic activity for EGFRWT (IC50 = 1.07) to Osimertinib.

Sign In Join Free